TeleLifestyleCoaching Use of Telemedicine for Weight Loss and Care of Weight Associated Illnesses
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 180
- Locations
- 2
- Primary Endpoint
- weight loss
Study Overview
Brief Summary
Lifestyle changes often fail due to loss of motivation. Telemedicine and personal coaching have the potential to support lifestyle change and weight loss. Therefore, the aim of our randomized controlled trial was to examine the effect of telemedicine with and without coaching in comparison to a control group on weight loss in overweight participants.
Detailed Description
In an occupational health care setting overweight employees were randomized into a three arm 12-week trial. Participants in the telemedical (TM) and telemedical coaching (TMC) group got a weighing machine and a step counter, with automatic transfer into a personalized online portal, which could be monitored from both, the participant and the study centre. The TMC group weekly got care calls from the study centre aiming to discuss measured data and to fix target agreements. The control group remained in routine care. Wilcoxon signed rank test was used to determine if differences (baseline vs. after 12 weeks) were significantly different from 0 and ANOVA test for determination of inter group differences.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Supportive Care
- Masking
- Single (Outcomes Assessor)
Eligibility Criteria
- Ages
- 18 Years to 75 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •BMI ≥27 kg/m2
Exclusion Criteria
- •Hypoglycemia inducing medication
- •severe disease with hospital stay during the last 3 months
- •smoking cessation for less then 3 months
- •planned smoking cessation during study phase
- •acute infects
- •chronic diseases
Outcomes
Primary Outcomes
weight loss
Time Frame: 12 weeks
Weight will be measured at baseline and after 12 weeks
Secondary Outcomes
- cardiometabolic risk factors(12 weeks)
Investigators
Stephan Martin
Director
West German Center of Diabetes and Health